Showing results (101-110 of 312) with videos related to
Sort By:
Pageof 32
Experimental Cell Research|April 9, 2018
Reduced substrate stiffness promotes M2-like macrophage activation and enhances peroxisome proliferator-activated receptor γ expressionTakayuki Okamoto, Yoshimi Takagi, Eiji Kawamoto, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 15, 2021
Endothelial connexin-integrin crosstalk in vascular inflammationTakayuki Okamoto, Eun Jeong Park, Eiji Kawamoto, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanismSimona Podgrabinska, Okebugwu Kamalu, Lloyd Mayer, et al.Current Pharmaceutical Design|November 19, 2019
Exosomes in Sepsis and Inflammatory Tissue InjuryEun J Park, Michael G Appiah, Phyoe K Myint, et al.Blood|July 7, 2007
Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signalingJieqing Zhu, Christopher V Carman, Minsoo Kim, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2Thomas Vorup-Jensen, Christopher V Carman, Motomu Shimaoka, et al.Current Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan PeerJournal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan PeerDrug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan PeerBioconjugate Chemistry|January 7, 2016
Transforming Nanomedicines From Lab Scale Production to Novel Clinical ModalityDalit Landesman-Milo, Dan PeerPageof 32